Page last updated: 2024-10-28

fasudil and Lesion of Sciatic Nerve

fasudil has been researched along with Lesion of Sciatic Nerve in 2 studies

fasudil: intracellular calcium antagonist; structure in first source
fasudil : An isoquinoline substituted by a (1,4-diazepan-1-yl)sulfonyl group at position 5. It is a Rho-kinase inhibitor and its hydrochloride hydrate form is approved for the treatment of cerebral vasospasm and cerebral ischemia.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cheng, C1
Webber, CA1
Wang, J1
Xu, Y1
Martinez, JA1
Liu, WQ1
McDonald, D1
Guo, GF1
Nguyen, MD1
Zochodne, DW1
Hiraga, A1
Kuwabara, S1
Doya, H1
Kanai, K1
Fujitani, M1
Taniguchi, J1
Arai, K1
Mori, M1
Hattori, T1
Yamashita, T1

Other Studies

2 other studies available for fasudil and Lesion of Sciatic Nerve

ArticleYear
Activated RHOA and peripheral axon regeneration.
    Experimental neurology, 2008, Volume: 212, Issue:2

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Axons; Axotomy; Cells, Cultured; Disease Mod

2008
Rho-kinase inhibition enhances axonal regeneration after peripheral nerve injury.
    Journal of the peripheral nervous system : JPNS, 2006, Volume: 11, Issue:3

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Action Potentials; Animals; Enzyme Activation; Intrac

2006